United States: Treatment Of Antibody Claims In The U.S. After Amgen v. Sanofi - Harness IP
Monday, 19 February 2024
The future of antibody claiming in the United States is uncertain following the U.S. Supreme Court's May 2023 ruling in Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), a highly anticipated decision...
|
||||
You Might Like |
||||
